Topic Review
Fibroblasts
Fibroblasts, the most abundant cells in the connective tissue, are key modulators of the extracellular matrix (ECM) composition.
  • 1.0K
  • 18 Jan 2021
Topic Review
Perinatal Stem Cells
Perinatal tissues refer to tissues that are discarded at birth, such as the placenta, umbilical cord, cord blood, and amniotic fluid, and different stem and progenitor cell types can be isolated from these tissues. Regenerative medicine has found in the perinatal medical wastes one of the most promising sources of various cells and tissues for use in cell therapy and tissue engineering, both in experimental and clinical settings. The primary source of perinatal stem cells is cord blood. Cord blood has been a well-known source of hematopoietic stem/progenitor cells. Other perinatal tissues contain non-hematopoietic cells with potential therapeutic value. Indeed, in advanced perinatal cell therapy trials, mesenchymal stromal cells are the most commonly used.
  • 3.7K
  • 14 Jan 2021
Topic Review
Flow Cytometry and Respiratory Diseases
Flow cytometry (FCM) arises with the design of the cell spectrophotometer, which makes it possible to measure both the content of nucleic acids and the size of the analyzed cells. The subject of the study is not limited to humans, other animal species and bacterias can also be studied. Moreover, FCM allows identify expression of molecules in the membrane, cytoplasm or nucleus, beside soluble proteins (cytokines, chemokines, etc), extracellular vesicles, antibodies, etc.
  • 899
  • 14 Jan 2021
Topic Review
Lipid Metabolism
  Bone is a dynamic tissue and is constantly being remodeled by bone cells. Metabolic reprogramming plays a critical role in the activation of these bone cells and skeletal metabolism, which fulfills the energy demand for bone remodeling. Among various metabolic pathways, the importance of lipid metabolism in bone cells has long been appreciated. More recent studies also establish the link between bone loss and lipid-altering conditions—such as atherosclerotic vascular disease, hyperlipidemia, and obesity—and uncover the detrimental effect of fat accumulation on skeletal homeostasis and increased risk of fracture. Targeting lipid metabolism with statin, a lipid-lowering drug, has been shown to improve bone density and quality in metabolic bone diseases. However, the molecular mechanisms of lipid-mediated regulation in osteoclasts are not completely understood. Thus, a better understanding of lipid metabolism in osteoclasts can be used to harness bone cell activity to treat pathological bone disorders.
  • 762
  • 14 Jan 2021
Topic Review
T(8;21) Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogenous disease with multiple sub-types which are defined by different somatic mutations that cause blood cell differentiation to go astray.  One of the best-studied AML-subtypes is the t(8;21) AML which carries a translocation fusing sequences encoding the DNA-binding domain of the hematopoietic master regulator RUNX1 to the ETO gene. 
  • 639
  • 13 Jan 2021
Topic Review
Convection Enhanced Delivery
Convection enhanced delivery (CED), first described by Bobo et al. in 1994, remains a promising technique for circumventing the Blood Brain Barrier (BBB) and delivering therapy in a non-diffusion dependent manner, thereby facilitating high local concentrations of infusate.
  • 1.0K
  • 12 Jan 2021
Topic Review
Connexins and cAMP
Cyclic adenosine monophosphate (cAMP) is a small molecule that acts as a second messenger in mediating intracellular signal transduction.
  • 595
  • 12 Jan 2021
Topic Review
Notch in Hematological Malignancies
Notch receptors are single-pass transmembrane proteins that play a critical role in cell fate decisions and have been implicated in the regulation of many developmental processes. The human Notch family comprises of four receptors (Notch 1 to 4) and five ligands. Their signaling can regulate extremely basic cellular processes such as differentiation, proliferation and death. Notch is also involved in hematopoiesis and angiogenesis, and increasing evidence suggests that these genes are involved and frequently deregulated in several human malignancies, contributing to cell autonomous activities that may be either oncogenic or tumor suppressive. It was recently proposed that Notch signaling could play an active role in promoting and sustaining a broad spectrum of lymphoid malignancies as well as mutations in Notch family members that are present in several disorders of T- and B-cells, which could be responsible for altering the related signaling. Therefore, different Notch pathway molecules could be considered as potential therapeutic targets for hematological cancers.
  • 433
  • 12 Jan 2021
Topic Review
Sodium-Glucose Cotransporter-2 Inhibitors
Recent randomized controlled trials (RCTs) tested the efficacy of sodium-glucose cotransporter-2 (SGLT-2) inhibitors to specifically treat nonalcoholic fatty liver disease (NAFLD). We systematically searched three large electronic databases (up to 31 October 2020) for identifying placebo-controlled or active-controlled RCTs that used different SGLT-2 inhibitors (dapagliflozin, empagliflozin, ipragliflozin or canagliflozin) for treatment of NAFLD.
  • 441
  • 11 Jan 2021
Topic Review
MicroRNAs in Cutaneous Autoimmune Diseases
MicroRNAs (miRNAs) are endogenous small non-coding RNA molecules that regulate the gene expression at a post-transcriptional level and participate in maintaining the correct cell homeostasis and functioning. Different specific profiles have been identified in lesional skin from autoimmune cutaneous diseases, and their deregulation cause aberrant control of biological pathways, contributing to pathogenic conditions. 
  • 513
  • 08 Jan 2021
  • Page
  • of
  • 161
Video Production Service